Assessing GPT‐4's accuracy in answering clinical pharmacological questions on pain therapy
GPT-4 demonstrates potential as a tool for delivering medical information, particularly in pain management. However, limitations such as incomplete pharmacological data and the potential for contextual carryover in follow-up questions suggest that further refinement is necessary. Developing specialized artificial intelligence tools that integrate real-time pharmacological databases could improve accuracy and reliability for clinical decision-making.
Authors
- Moritz Wegner (ORCID: https://orcid.org/0000-0003-0601-9223)
- Ralf Stroop (ORCID: https://orcid.org/0000-0001-8795-6790)
- Makoto Nakamura (ORCID: https://orcid.org/0000-0002-6464-4302)
- Samer Zawy Alsofy (ORCID: https://orcid.org/0000-0002-9592-3881)
- Anna Stroop
- Tabea Stroop
Institutions
- Witten/Herdecke University (DE)
- Philipps University of Marburg (DE)
- University of Cologne (DE)
- MSH Medical School Hamburg – University of Applied Sciences and Medical University (DE)
- University Hospital Münster (DE)
- University Hospital Cologne (DE)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1002/bcp.70036
- Citations
- 4
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.90